Sarah
LESJEAN
sarah.lesjean@inserm.fr
BIOSKETCH
-
PATENTS
-
-
Use of Glypican-3-targeting microRNAs for treating liver cancer. n° B2058PC00; PCT/EP2016/065933 06/07/2016 European patent UNIVERSITE DE BORDEAUX-INSERM Cartier, F., Lesjean, S., Sagliocco, F., and Grosset, C. -
Use of catenin-beta 1-targeting microRNAs for treating liver cancer. n°B2059PC00; PCT/EP2016/065938 06/07/2016 European patent UNIVERSITE DE BORDEAUX-INSERM-UNIVERSITE PARIS SUD - PARIS XI Indersie E., Lesjean S., Sagliocco F., Buenda M.-A., and Grosset, C.
-